{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:00:02Z","timestamp":1780920002842,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44029-y","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:17:36Z","timestamp":1776269856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive ductal and lobular carcinoma and receptor status in the genetic context of breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Mahmoud","family":"Al-Masri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Alayyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"5","key":"44029_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"Breast Cancer Association Consortium","year":"2021","unstructured":"Breast Cancer Association Consortium. Breast Cancer Risk Genes \u2014 Association Analysis in More than 113,000 Women. N Engl. J. Med. 384(5), 428\u2013439 (2021).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"44029_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13045-019-0725-6","volume":"12","author":"ZS Lima","year":"2019","unstructured":"Lima, Z. S. et al. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. J. Hematol. OncolJ Hematol. Oncol. 12(1), 38 (2019).","journal-title":"J. Hematol. OncolJ Hematol. Oncol."},{"issue":"35","key":"44029_CR3","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.21.00640","volume":"39","author":"S Yadav","year":"2021","unstructured":"Yadav, S. et al. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. J. Clin. Oncol. 39(35), 3918\u20133926 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"44029_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/jnci\/djaa023","volume":"112","author":"C Hu","year":"2020","unstructured":"Hu, C. et al. The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort. JNCI J. Natl. Cancer Inst. 112(12), 1231\u20131241 (2020).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"4","key":"44029_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1258\/136218003323010584","volume":"9","author":"K Von Smitten","year":"2003","unstructured":"Von Smitten, K. Prophylactic mastectomy: why and when? Br. Menopause Soc. J. 9(4), 151\u2013155 (2003).","journal-title":"Br. Menopause Soc. J."},{"issue":"9","key":"44029_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","volume":"93","author":"CI Li","year":"2005","unstructured":"Li, C. I., Uribe, D. J. & Daling, J. R. Clinical characteristics of different histologic types of breast cancer. Br. J. Cancer. 93(9), 1046\u20131052 (2005).","journal-title":"Br. J. Cancer"},{"issue":"11","key":"44029_CR7","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/ijc.32182","volume":"145","author":"M Dianatinasab","year":"2019","unstructured":"Dianatinasab, M. et al. Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case\u2013control study. Int. J. Cancer. 145(11), 2917\u20132925 (2019).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"44029_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13058-015-0546-7","volume":"17","author":"L Dossus","year":"2015","unstructured":"Dossus, L. & Benusiglio, P. R. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res. 17(1), 37 (2015).","journal-title":"Breast Cancer Res."},{"issue":"1","key":"44029_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/tbj.13154","volume":"25","author":"Y Ditchi","year":"2019","unstructured":"Ditchi, Y. et al. Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations. Breast J. 25(1), 16 (2019).","journal-title":"Breast J."},{"issue":"1","key":"44029_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1477-7819-12-56","volume":"12","author":"ST Lim","year":"2014","unstructured":"Lim, S. T. et al. A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population. World J. Surg. Oncol. 12(1), 56 (2014).","journal-title":"World J. Surg. Oncol."},{"issue":"5","key":"44029_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3816\/CBC.2006.n.056","volume":"7","author":"AM Gonzalez-Angulo","year":"2006","unstructured":"Gonzalez-Angulo, A. M. et al. Biologic Markers in Axillary Node-Negative Breast Cancer: Differential Expression in Invasive Ductal Carcinoma Versus Invasive Lobular Carcinoma. Clin. Breast Cancer. 7(5), 396\u2013400 (2006).","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"44029_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","volume":"23","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli, M. et al. Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes. J. Clin. Oncol. 23(1), 41\u201348 (2005).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"44029_CR13","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/jnci\/djac157","volume":"114","author":"S Oesterreich","year":"2022","unstructured":"Oesterreich, S. et al. Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer. JNCI J. Natl. Cancer Inst. 114(11), 1511\u20131522 (2022).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"1","key":"44029_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat, N. et al. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 \/ 2(CIMBA). Cancer Epidemiol. Biomarkers Prev. 21(1), 134\u2013147 (2012).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"8","key":"44029_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","volume":"110","author":"H Shimelis","year":"2018","unstructured":"Shimelis, H. et al. Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. JNCI J. Natl. Cancer Inst. 110(8), 855\u2013862 (2018).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"3","key":"44029_CR16","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1186\/bcr767","volume":"6","author":"G Arpino","year":"2004","unstructured":"Arpino, G., Bardou, V. J., Clark, G. M. & Elledge, R. M. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 6(3), R149 (2004).","journal-title":"Breast Cancer Res."},{"issue":"6","key":"44029_CR17","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1002\/onco.13734","volume":"26","author":"N Pramod","year":"2021","unstructured":"Pramod, N. et al. Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer. Oncologist 26(6), e943\u2013e953 (2021).","journal-title":"Oncologist"},{"issue":"4","key":"44029_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/ejso.2002.1423","volume":"29","author":"H Mersin","year":"2003","unstructured":"Mersin, H., Y\u0131ld\u0131r\u0131m, E., G\u00fclben, K. & Berbero\u011flu, U. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur. J. Surg. Oncol. EJSO. 29(4), 390\u2013395 (2003).","journal-title":"Eur. J. Surg. Oncol. EJSO"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44029-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:04:44Z","timestamp":1780916684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44029-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44029"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44029-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the King Hussein Cancer Center on 17 July 2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"17582"}}